0000899243-22-027444.txt : 20220802
0000899243-22-027444.hdr.sgml : 20220802
20220802182911
ACCESSION NUMBER: 0000899243-22-027444
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220728
FILED AS OF DATE: 20220802
DATE AS OF CHANGE: 20220802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Guerrero Ramiro
CENTRAL INDEX KEY: 0001913253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41455
FILM NUMBER: 221130392
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAIA Biotechnology, Inc.
CENTRAL INDEX KEY: 0001878313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
BUSINESS PHONE: 312-416-8592
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-28
0
0001878313
MAIA Biotechnology, Inc.
MAIA
0001913253
Guerrero Ramiro
444 WEST LAKE STREET,
SUITE 1700
CHICAGO
IL
60606
1
0
0
0
Common Stock
2022-07-28
4
P
0
9000
4.00
A
268382
D
Common Stock
2022-08-01
4
P
0
20000
5.00
A
288382
D
These shares were purchased by the reporting person in the open market for $4.00 per share on July 28, 2022.
These shares were purchased by the reporting person in the issuer's initial public offering, which closed on August 1, 2022.
/s/ Ramiro Guerrero
2022-08-02